Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys Shares of 33,644 Stryker Co. (SYK)
Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Stryker Co. (NYSE:SYK) during the second quarter, HoldingsChannel.com reports. The fund bought 33,644 shares of the medical technology company’s stock, valued at approximately $5,681,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Kaizen Advisory LLC grew its position in shares of Stryker by 142.6% in the 2nd quarter. Kaizen Advisory LLC now owns 752 shares of the medical technology company’s stock valued at $127,000 after buying an additional 442 shares during the last quarter. CX Institutional purchased a new position in shares of Stryker in the 2nd quarter valued at $133,000. Bruderman Asset Management LLC purchased a new position in shares of Stryker in the 1st quarter valued at $152,000. Ostrum Asset Management purchased a new position in shares of Stryker in the 1st quarter valued at $160,000. Finally, Private Capital Group LLC grew its position in shares of Stryker by 1,218.4% in the 1st quarter. Private Capital Group LLC now owns 1,002 shares of the medical technology company’s stock valued at $162,000 after buying an additional 926 shares during the last quarter. 74.72% of the stock is currently owned by hedge funds and other institutional investors.
SYK has been the topic of a number of recent analyst reports. Zacks Investment Research raised shares of Stryker from a “hold” rating to a “buy” rating and set a $192.00 target price on the stock in a research report on Monday, May 21st. Canaccord Genuity increased their target price on shares of Stryker from $176.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 27th. Stifel Nicolaus increased their price target on shares of Stryker from $183.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday, April 27th. ValuEngine upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. Finally, Royal Bank of Canada reiterated a “buy” rating and set a $184.00 price target on shares of Stryker in a research note on Wednesday, July 25th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. Stryker has an average rating of “Buy” and an average target price of $175.90.
Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, July 24th. The medical technology company reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.73 by $0.03. Stryker had a net margin of 8.28% and a return on equity of 26.93%. The firm had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.31 billion. During the same quarter in the prior year, the business earned $1.53 EPS. Stryker’s quarterly revenue was up 10.3% compared to the same quarter last year. research analysts expect that Stryker Co. will post 7.25 earnings per share for the current fiscal year.
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Featured Article: Average Daily Trade Volume Explained
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.